76 results
8-K
EX-10.2
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.3
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.4
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.1
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.5
jd7h xmjtu
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.1
ajs9frk76 dw6hd
13 Dec 22
Departure of Directors or Certain Officers
9:02am
8-K
EX-10.1
kg2x5b9gco5h
27 Jul 22
Departure of Directors or Certain Officers
7:26am
8-K
EX-10.2
qpf5hbujnu1
27 Jul 22
Departure of Directors or Certain Officers
7:26am
8-K
EX-10.1
1w4m4f4p3xbb vwf5
25 Jul 22
Entry into a Material Definitive Agreement
7:11am
8-K
EX-10.1
f6n ck97f6v7431
2 Dec 21
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.2
xagebc c1
20 Oct 21
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.1
cnd625n8ac8fd
20 Oct 21
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.3
24001lpv4ge9u9x
20 Oct 21
Departure of Directors or Certain Officers
9:00am